Logo

IDT: Demaris Mills

Sep 08, 2021

Demaris Mills has been appointed president of biotechnology company IDT. She succeeds Trey Martin, who took a position in the genomic medicine division of Danaher, IDT's parent company. Mills has over 12 years experience within Danaher companies, previously serving as president of Phenomenex and in several roles with Beckman Coulter, including VP and general manager of the genomics and liquid handling businesses; VP of European sales; VP of global marketing; and leader of product management for the Leica Biosystems consumables business. She holds an MBA from Harvard Business School and a bachelor's degree in economics and French from Smith College.

Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.